CN105267757A - 一种用于产后自汗治疗与护理的中药丸剂及制备方法 - Google Patents
一种用于产后自汗治疗与护理的中药丸剂及制备方法 Download PDFInfo
- Publication number
- CN105267757A CN105267757A CN201510821834.3A CN201510821834A CN105267757A CN 105267757 A CN105267757 A CN 105267757A CN 201510821834 A CN201510821834 A CN 201510821834A CN 105267757 A CN105267757 A CN 105267757A
- Authority
- CN
- China
- Prior art keywords
- radix
- immersion
- medicine
- blood
- subsequent use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 230000002269 spontaneous effect Effects 0.000 title claims abstract description 36
- 239000006187 pill Substances 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title abstract 2
- 230000035900 sweating Effects 0.000 claims abstract description 33
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 239000004615 ingredient Substances 0.000 claims abstract description 10
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 8
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 4
- 235000009566 rice Nutrition 0.000 claims abstract description 4
- 240000007594 Oryza sativa Species 0.000 claims abstract 2
- 208000008454 Hyperhidrosis Diseases 0.000 claims description 33
- 239000000843 powder Substances 0.000 claims description 27
- 238000007654 immersion Methods 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 19
- 238000010410 dusting Methods 0.000 claims description 12
- 238000010298 pulverizing process Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 230000000474 nursing effect Effects 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 241001441970 Anserinae Species 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 210000002615 epidermis Anatomy 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 235000019991 rice wine Nutrition 0.000 claims description 6
- 239000000052 vinegar Substances 0.000 claims description 6
- 235000021419 vinegar Nutrition 0.000 claims description 6
- 244000025254 Cannabis sativa Species 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 235000012907 honey Nutrition 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 244000054471 Hiptage benghalensis Species 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 51
- 210000004369 blood Anatomy 0.000 abstract description 50
- 210000000952 spleen Anatomy 0.000 abstract description 34
- 230000000694 effects Effects 0.000 abstract description 26
- 210000003734 kidney Anatomy 0.000 abstract description 23
- 210000004072 lung Anatomy 0.000 abstract description 23
- 210000002216 heart Anatomy 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 20
- 238000005728 strengthening Methods 0.000 abstract description 11
- 230000002936 tranquilizing effect Effects 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000007320 Avena fatua Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000407877 Combretum Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 244000289453 Parkinsonia aculeata Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 244000308495 Potentilla anserina Species 0.000 abstract 1
- 235000009728 Potentilla anserina subsp anserina Nutrition 0.000 abstract 1
- 241000882349 Pseudostellaria maximowicziana Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000005601 Trisetum Species 0.000 abstract 1
- 241001556408 Ventilago leiocarpa Species 0.000 abstract 1
- 241000949456 Zanthoxylum Species 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 23
- 235000009508 confectionery Nutrition 0.000 description 22
- 210000002784 stomach Anatomy 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 206010033557 Palpitations Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 210000003205 muscle Anatomy 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 241000411851 herbal medicine Species 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 230000035922 thirst Effects 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 230000002950 deficient Effects 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 238000012790 confirmation Methods 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 230000036565 night sweats Effects 0.000 description 6
- 206010029410 night sweats Diseases 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 230000009429 distress Effects 0.000 description 5
- 241001640032 Hiptage Species 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000000242 pagocytic effect Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010002660 Anoxia Diseases 0.000 description 3
- 241000976983 Anoxia Species 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000005946 Xerostomia Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000007953 anoxia Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 229940124567 diuretic antihypertensive agent Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000003664 filaricide agent Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000027692 gas pain Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000292 leukogenic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000009874 shenqi Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于产后自汗治疗与护理的中药丸剂及制备方法,属中药领域。本发明药物有效成分的原料组成为:糯稻根、当归、龙眼肉、白术、血风藤、蕨麻、燕麦草、黄芪、风车藤、红芪、黑芝麻、桂枝、夜交藤、黄精、扁轴木、玉竹、棒棒草、大枣、牡丹皮、白芍、地骨皮、石斛、吊吊果、柏子仁。本发明选用药材药性相适相辅,针对病因对症下药,有补益肝肾、健脾润肺、益气补血、补气固表、固表止汗、滋阴清热、调和营卫、养心安神之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对产后自汗治愈率较高。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种用于产后自汗治疗与护理的中药丸剂及制备方法。
背景技术
产妇于产后2~3天内出汗较多,为正常现象,其后应逐渐减少而止。若产妇产后出汗过多,或出汗时间过长而不能自止,且动则加剧,恶风,并出现面色发白,气短懒言,语声低快,倦怠乏力,舌淡,苔薄,脉虚弱等症状者,称为产后自汗。
目前西医对于产后自汗并无特效药物,只是进行一般性的药物对症治疗,疗效并不理想,且具有一定的副作用,一般不建议服用西医药物治疗。
中医认为产后自汗的病因是素体虚弱,产时伤血,气随血耗,卫阳不固,腠理不实所致。汗为心液,营为汗液的物质基础,营卫失调,汗液外溢不止,遂成自汗。本发明所述的药丸是经长期临床对症治疗总结配置而成,针对患者产后的失血耗气,气营两伤,营血不足,卫阳不固的身体状况,对症下药,具有补益肝肾、健脾润肺、益气补血、补气固表、固表敛汗、滋阴清热、调和营卫、养心安神之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对产后自汗治愈率较高。
发明内容
本发明提供了一种用于产后自汗治疗与护理的中药丸剂及制备方法,具有补益肝肾、健脾润肺、益气补血、补气固表、固表敛汗、滋阴清热、调和营卫、养心安神之功效,治病求源标本兼治,对产后自汗具有很好的疗效。
为实现上述目的,本发明的技术方案实施如下:
一种用于产后自汗治疗与护理的中药丸剂,制成所述药物有效成分的原料组成及重量份数为:
制成所述药物有效成分的原料组成及重量份数为:
制成所述药物有效成分的原料组成及重量份数为:
一种用于产后自汗治疗与护理的中药丸剂的制备方法,包括以下工艺步骤:
(1)将糯稻根、蕨麻、燕麦草、风车藤、黑芝麻、桂枝、夜交藤、黄精、扁轴木、玉竹、棒棒草、大枣、牡丹皮、地骨皮、石斛、吊吊果洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸3~4小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸2~3小时,冷却后浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(2)将当归、龙眼肉、血风藤、白芍放入容器中,加入3~5倍量的绍兴黄酒,煮沸后放凉,继续浸泡3~5小时,取浸液;在剩余的药渣中再加入2~4倍量的绍兴黄酒,煮沸后放晾,继续浸泡2~4小时,取浸液;合并两次所得浸液,加蒸蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(3)将白术放入铁锅中,文火微炒,炒至表皮变黄后,喷洒即墨老酒,继续炒至表皮焦黄后,取出放凉,粉碎研末,过120目细筛,得细粉,备用;
(4)将黄芪洗净放入容器中,加定量的米醋拌匀,闷润至醋被吸尽后,置炒制容器内,用文火加热炒干,取出晾凉,筛去碎屑,粉碎研末,过120目细筛,得细粉,备用;
(5)将红芪加入炼熟的蜂蜜与少许开水,拌匀后稍闷,炒至黄色至深黄色,不粘手时取出,烘干粉碎研末,过120目细筛,得细粉,备用;
(6)将柏子仁洗净烘干后,粉碎研末,过120目细筛,得细粉,备用;
(7)将步骤(1)、步骤(2)所得的稠膏,与步骤(3)、步骤(4)、步骤(5)、步骤(6)中所得的细粉混合,加入炼蜜搅拌均匀后,制备为每粒8g的药丸。
本发明所用中药的药性如下:
糯稻根:味甘;性平。归肝经;养阴除热;止汗。主治阴虚发热;自汗盗汗;口渴咽干;肝炎;丝虫病。
当归:味甘;辛;性温。归肝、心、脾经。补血活血;调经止痛;润肠通便。主治血虚萎黄;眩晕心悸;虚寒腹痛;风湿痹痛;跌扑损伤;痈疽疮疡。《本草正》载:“其味甘而重,故专能补血,其气轻而辛,故又能行血,能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。”现代医学研究证实,当归具有抗菌、消炎作用,对慢性风湿关节炎急性发作有明显的抑制作用。
龙眼肉:味甘;性温。入心;肾;肝;脾经。补心脾;益气血;安心神。主治心脾两虚、气血不足所致的惊悸;怔忡;失眠;健忘;血虚萎黄;月经不调;崩漏。《得配本草》载:“益脾胃,葆心血,润五脏,治怔忡。”现代医学研究证实,龙眼肉对心肌遭受低温、高温和缺氧刺激有明显的保护作用,对奥杜盎氏小芽胞癣菌有抑制作用,此外还有镇静和健胃作用。
白术:味苦;甘;性温。归脾;胃经。健脾益气;燥湿利水;止汗;安胎。主治脾气虚弱;神疲乏力;食少腹胀;大便溏薄;水饮内停;小便不利;水肿;痰饮眩晕;湿痹酸痛;气虚自汗;胎动不安。《本经逢原》载:“术,生用有除湿益燥,消痰利水,治风寒湿痹,死肌痉疸,散腰脐间血,及冲脉为病,逆气里急之功;制熟则有和中补气,止渴生津,止汗除热,进饮食,安胎之效。”现代医学研究证实,白术有强壮和提高机体抗病能力的作用,增强网状内皮系统的吞噬功能,增强白细胞吞噬金黄色葡萄球菌的功能,对白细胞减少症有升白作用,提高淋巴细胞转化率,促进细胞免疫功能,对金黄色葡萄球菌、溶血性链球菌、绿色链球菌、肺炎球菌、脑膜炎球菌、白喉杆菌、枯草杆菌有不同程度的抑制作用,对絮状表皮癣菌、星形奴卡菌、堇色毛癣菌、同心性毛癣菌等皮肤真菌有一定的抑制作用。
血风藤:味甘;性温。归肺;脾经。补气血;强筋骨;舒经络。主治气血虚弱;有经不调;血虚经闭;风湿疼痛;跌打损伤;腰肌劳损。《常用中草药手册》:补气补血,舒筋活络。治气血亏损,月经不调,风湿筋骨痛,四肢麻木,跌打损伤。
蕨麻:味甘;苦;寒。归脾;胃经。补气血,健脾胃,生津止渴,利湿。用于病后贫血,营养不良,脾虚腹泻,风湿痹痛。《西藏常用中草药》:"健脾益胃,生津止渴,益气补血,治脾虚腹泻,病后贫血,营养不良。"现代研究证明:蕨麻含收缩及松弛平滑肌的两种成分,对平滑肌有一定影响,并有强心作用。
燕麦草:味甘;性平。收敛止血;固表止汗。主治吐血;便血;血崩;自汗;盗汗;白带。
黄芪:味甘;性温。入心;肺;脾;肾经。补气固表;利尿;托毒排脓;生肌敛疮。主治气短心悸;倦怠;乏力;自汗;盗汗;久泻;脱肛;体虚浮肿;子宫脱垂;慢性肾炎;痈疽难溃;或溃久不敛。《新华本草纲要》载:“有补气固表、托毒排脓、生肌的功能。”现代医学研究证实,黄芪主要成分为黄芪总黄酮、黄芪总多糖、黄芪总皂苷和氨基酸等,具有利尿降压、消炎镇痛、强心、抗氧自由基生成及提高机体免疫功能等多种药理作用,可从多方面作用于机体,改善心血管、脑血管、糖尿病、肾病等相关血管性病变患者的血流动力学和血管内皮细胞等功能。
风车藤:味涩;微苦;性温。归肾经。温肾益气;涩精止遗。主治肾虚阳痿;遗精;尿频;自汗盗汗;风寒湿痹。
红芪:味甘;性温。归肺脾经。固表止汗;补气利尿;托毒敛疮。主治气虚乏力;食少便溏;久泻脱肛;便血;崩漏;表虚自汗;气虚浮肿;血虚萎黄;痈疽难溃难敛。
黑芝麻:味甘;性平。归肝;脾;肾经。补益肝肾;养血益精;润肠通便。用于头晕眼花,耳鸣耳聋,须发早白,病后脱发,肠燥便秘。现代医学研究证明:黑芝麻具有降血糖作用、促肾上腺作用、抗炎作用及对心血管有一定作用。
桂枝:味辛;甘;性温。入膀胱;心;肺经。散寒解表;温通经脉;通阳化气。主治风寒表证;寒湿痹痛;四肢厥冷;经闭痛经;癓瘕结块;胸痹;心悸;痰饮;小便不利。《长沙药解》载:“入肝家而行血分,定经络而达荣郁。善解风邪,最调木气。升清阳之脱陷,降浊阴之冲逆,舒筋脉之急挛;利关节之壅阻。入肝胆而散遏抑,极止痛楚,通经络而开痹涩,甚去湿寒。能止奔豚,更安惊悸。”现代医学研究证实,桂枝能有效扩张血管、促进发汗,所含的桂皮醛、桂皮酸钠有解热、镇痛、镇静、抗惊厥作用,此外桂枝还有抗菌、抗病毒的功效。
夜交藤:味甘;微苦;性平。入心;肝经。养心安神;祛风;通络。主治失眠;多梦;血虚身痛;肌肤麻木;风湿痹痛;风疹瘙痒。《饮片新参》载:“养肝肾,止虚汗,安神催眠,补中气,行经络,通血脉,治劳伤。”现代医学研究证实,夜交藤含有大黄素、大黄素甲醚,与戊巴比妥钠呈协同作用,有显著的镇静、催眠作用,尤其是延长慢波睡眠时相。
黄精:味甘;性平。入脾;肺;肾经。养阴润肺;补脾益气;滋肾填精。主治阴虚劳嗽;肺燥咳嗽;脾虚乏力;食少口干;消渴;肾亏腰膝酸软;阳痿遗精;耳鸣目暗;须发早白;体虚羸瘦;风癞癣疾。《本草逢原》载:“宽中益气,使五藏调和,肌肉充盛,骨髓强坚,皆是补阴之功。”现代医学研究证实,黄精对肾上腺素引起的血糖升高有显著的抑制作用,对常见致病真菌有不同程度的抑制作用,升高肝脏超氧化物歧化酶活性,降低心肌脂褐质含量降低,增强对缺氧的耐受力,此外还有抗病毒功效。
扁轴木:味微甘;性平。归肾;脾经。补益。主治身体衰弱;劳伤乏力;虚热;自汗;盗汗。《新华本草纲要》:树皮及枝叶有补虚劳的功能。用于一般身体衰弱。
玉竹:味甘;性平。入肺;胃经。滋阴润肺;养胃生津。主治燥咳;劳嗽;热病阴液耗伤之咽干口渴;内热消渴;阴虚外感;头昏眩晕;筋脉挛痛。《日华子本草》载:“除烦闷,止渴,润心肺,补五劳七伤,虚损,腰脚疼痛,天行热狂。”现代医学研究证实,玉竹有短暂的降压和强心作用,对肾上腺素所致高血糖有明显的降低作用,能扩张肢体血管,缓解动脉粥样硬化斑块的形成,提高血清溶血素抗体水平,增强巨噬细胞的吞噬功能,改善淋巴细胞对ConA的增殖反应。
棒棒草:味甘;苦;性微温。补肺;健脾;养阴生津。主治肺虚咳嗽;脾虚食少;心悸自汗;疲惫乏力;口干。
大枣:味甘;温。归脾;胃经。补脾胃;益气血;安心神;调营卫;和药性。主治脾胃虚弱;气血不足;食少便溏;倦怠乏力;心悸失眠;妇人脏躁;营卫不和。《本草汇言》:沈氏曰,此药甘润膏凝,善补阴阳、气血、津液、脉络、筋俞、骨髓,一切虚损,无不宜之。如龙谭方治惊悸怔忡,健忘恍惚,志意昏迷,精神不守,或中气不和,饮食无味,百体懒重,肌肉瘦,此属心、脾二藏元神亏损之证,必用大枣治之。佐用陈皮,调畅中脘虚滞之痰。
牡丹皮:味辛苦;性凉,微寒,归心;肝;肾;肺经。清热凉血,活血化瘀。主治:温热病热入血分;发斑;吐衄;热泪盈眶病菌后期热伏阴分发热;阴虚骨蒸潮热;血滞经闭;痛经;痈肿疮毒;跌扑伤痛;风湿热痹。《本草纲目》:牡丹皮,治手足少阴、厥阴四经血分伏火。盖伏火即阴火也,阴火即相火也,古方惟以此治相火,故仲景肾气丸用之。后人乃专以黄蘖治相火,不知丹皮之功更胜也。赤花者利,白花者补,人亦罕悟,宜分别之。
白芍:味苦;性平。入肝;脾经。养血柔肝,缓中止痛;敛阴收汗。主治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热。《别录》载:“通顺血脉,缓中,散恶血,逐贼血,去水气,利膀胱、大小肠,消痈肿,治时行寒热,中恶腹痛,腰痛。”现代医学研究证实,白芍能调节免疫,增强巨噬细胞和白细胞的吞噬功能,调节T淋巴细胞和体液的免疫功能,有保肝、解痉、镇痛、镇静、抗凉、降温作用,此外还对平滑肌有抑制作用,增强耐缺氧、抗氧化和抗疲劳的作用。
地骨皮:味甘;性寒。入肺;肾经。清虚热;泻肺火;凉血。主治阴虚劳热;骨蒸盗汗;小儿疳积发热;肺热喘咳;吐血;衄血;尿血;消渴。《本草述》载:“主治虚劳发热,往来寒热,诸见血证、鼻衄、咳嗽血,咳嗽、喘,消瘅,中风,眩晕,痉痫,腰痛,行痹,脚气,水肿,虚烦,悸,健忘,小便不通,赤白浊。”现代医学研究证实,地骨皮含有胍的衍生物,具有降血糖作用,对胰岛岛β细胞形态结构的损害有一定的减轻作用,能阻断交感神经末梢而直接舒张血管。
石斛:味甘;性微寒。归胃;肺;肾经。生津益胃;滋阴清热;润肺益肾;明目强腰。主治热病伤津;口干烦渴;胃阴不足;胃痛干呕;肺燥干咳;虚热不退;阴伤目蝉;腰膝软弱。《本草正》载:“石斛益精强阴,壮筋补虚,健脚膝,驱冷痹,却惊悸,定心志,有从容分解之妙,故能退火、养阴、除烦、清肺下气,亦止消渴热汗。”现代医学研究证实,石斛能显著增强巨噬细胞的吞噬作用,能抑制考的松或环磷酰胺所致的免疫,有显著的免疫激活作用,对环磷酰胺所致的白细胞下降有保护作用,并能明显提高鼻咽癌患者NK细胞的活性,能促进唾液、胃液、肠液分泌,能扩张微血管,增加血流,增强心肌收缩力,此外还有解热、镇痛等作用。
吊吊果:味酸;甘;性温。敛肺健胃;益肾强壮。主治久咳;自汗;盗汗;食欲不振;肾虚腰痛;神经衰弱。
柏子仁:味甘;性平。归心;肾;大肠经。养心安神;敛汗;润肠通便。主治惊悸怔忡;失眠健忘;盗汗;肠燥便秘。《药品化义》载:“香气透心,体润滋血,主治心神虚怯,惊悸怔忡,颜色憔悴,肌肤燥痒,皆养心血之功也。”现代医学研究证实,柏子仁含有大量不饱和脂肪酸、少量挥发油和多种维生素、皂苷、植物甾醇和蛋白质,提高机体免疫力,多用于治疗变异性心绞痛和风湿性冠心病。
本发明与现有技术相比,具有以下有益效果:
本发明选用药材的药性相适相辅,针对病因对症下药,有补益肝肾、健脾润肺、益气补血、补气固表、固表敛汗、滋阴清热、调和营卫、养心安神之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对产后自汗治愈率较高。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明药物有效成分的原料组成及重量为:
本发明药物制备方法的工艺步骤为:
(1)将糯稻根、蕨麻、燕麦草、风车藤、黑芝麻、桂枝、夜交藤、黄精、扁轴木、玉竹、棒棒草、大枣、牡丹皮、地骨皮、石斛、吊吊果洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸3~4小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸2~3小时,冷却后浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(2)将当归、龙眼肉、血风藤、白芍放入容器中,加入3~5倍量的绍兴黄酒,煮沸后放凉,继续浸泡3~5小时,取浸液;在剩余的药渣中再加入2~4倍量的绍兴黄酒,煮沸后放晾,继续浸泡2~4小时,取浸液;合并两次所得浸液,加蒸蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(3)将白术放入铁锅中,文火微炒,炒至表皮变黄后,喷洒即墨老酒,继续炒至表皮焦黄后,取出放凉,粉碎研末,过120目细筛,得细粉,备用;
(4)将黄芪洗净放入容器中,加定量的米醋拌匀,闷润至醋被吸尽后,置炒制容器内,用文火加热炒干,取出晾凉,筛去碎屑,粉碎研末,过120目细筛,得细粉,备用;
(5)将红芪加入炼熟的蜂蜜与少许开水,拌匀后稍闷,炒至黄色至深黄色,不粘手时取出,烘干粉碎研末,过120目细筛,得细粉,备用;
(6)将柏子仁洗净烘干后,粉碎研末,过120目细筛,得细粉,备用;
(7)将步骤(1)、步骤(2)所得的稠膏,与步骤(3)、步骤(4)、步骤(5)、步骤(6)中所得的细粉混合,加入炼蜜搅拌均匀后,制备为每粒8g的药丸。
用法用量:口服,每日2次,早晚各一次,每次1丸,以温开水送服,7天为一个疗程。
实施例2
本发明药物有效成分的原料组成及重量为:
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明药物有效成分的原料组成及重量为:
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择
选择我院确诊的产后自汗患者42例临床观察,女性,年龄25~42岁,平均年龄31.6岁。
2、患者服用本发明药物,口服,每日2次,早晚各一次,每次1丸,以温开水送服,7天为一个疗程。
3、疗效判定:
(1)治愈:临床症状明显消失,出汗及其他症状消失,3个月未复发。
(2)好转:临床症状明显缓解,出汗及其他症状明显减轻。
(3)无效:症状同施治前无明显差异。
4、结果
产后自汗患者治愈29例,好转9例,无效4例,治愈率69%,总有效率90.5%。
以上结果显示,本发明所述的药丸对产后自汗具有很好的疗效。
典型病例举例:
1、张××,女,32岁,文员。该患者剖腹产生孩子后,出汗一直很严重,身体虚弱未恢复,生产1个多月后,白天出汗仍然很严重,坐着不活动也出汗(屋里温度不高),上午出汗还稍少,下午出汗特别厉害,特别是下午3点到5点之间,后背上全是汗水。经服用本发明所述药丸1个疗程后,患者自汗症状明显减轻,遵医嘱继续服用本发明所述药丸1个疗程后,患者产后自汗症状完全消失,后3个月未复发,已痊愈。
2、夏××,女,28岁,工人。患者产后40天,吃饭喝水时仍大量出汗,坐卧时前心后背也时常出汗,还有身体乏力、说话气短等症状。经服用本发明所述药丸1个疗程后,患者产后自汗症状完全消失,后3个月未复发,已痊愈。
本发明所述的药丸是经过长期临床验证总结配置而成,针对病因对症下药,方中黑芝麻、龙眼肉、风车藤、石斛、棒棒草、扁轴木等中药补益肝肾、健脾润肺;方中黄芪补气固表;方中白术健脾益气,助黄芪益气固表;方中糯稻根、燕麦草、红芪等中药可固表止汗;方中当归、龙眼肉可养血安神;方中血风藤、蕨麻可补益气血;方中牡丹皮、地骨皮可清热凉血;方中桂枝温经解肌,白芍和营敛阴,两药合用,调和营卫;方中夜交藤、柏子仁可养心安神、敛汗;方中大枣可调营卫、和药性;方中诸药合用,共奏补益肝肾、健脾润肺、益气补血、补气固表、固表止汗、滋阴清热、调和营卫、养心安神之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对产后自汗治愈率较高。
Claims (4)
1.一种用于产后自汗治疗与护理的中药丸剂,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
2.根据权利要求1所述的一种用于产后自汗治疗与护理的中药丸剂,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
3.根据权利要求1所述的一种用于产后自汗治疗与护理的中药丸剂,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
4.一种用于产后自汗治疗与护理的中药丸剂的制备方法,其特征在于:包括以下工艺步骤:
(1)将糯稻根、蕨麻、燕麦草、风车藤、黑芝麻、桂枝、夜交藤、黄精、扁轴木、玉竹、棒棒草、大枣、牡丹皮、地骨皮、石斛、吊吊果洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸3~4小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸2~3小时,冷却后浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(2)将当归、龙眼肉、血风藤、白芍放入容器中,加入3~5倍量的绍兴黄酒,煮沸后放凉,继续浸泡3~5小时,取浸液;在剩余的药渣中再加入2~4倍量的绍兴黄酒,煮沸后放晾,继续浸泡2~4小时,取浸液;合并两次所得浸液,加蒸蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(3)将白术放入铁锅中,文火微炒,炒至表皮变黄后,喷洒即墨老酒,继续炒至表皮焦黄后,取出放凉,粉碎研末,过120目细筛,得细粉,备用;
(4)将黄芪洗净放入容器中,加定量的米醋拌匀,闷润至醋被吸尽后,置炒制容器内,用文火加热炒干,取出晾凉,筛去碎屑,粉碎研末,过120目细筛,得细粉,备用;
(5)将红芪加入炼熟的蜂蜜与少许开水,拌匀后稍闷,炒至黄色至深黄色,不粘手时取出,烘干粉碎研末,过120目细筛,得细粉,备用;
(6)将柏子仁洗净烘干后,粉碎研末,过120目细筛,得细粉,备用;
(7)将步骤(1)、步骤(2)所得的稠膏,与步骤(3)、步骤(4)、步骤(5)、步骤(6)中所得的细粉混合,加入炼蜜搅拌均匀后,制备为每粒8份的药丸。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510821834.3A CN105267757A (zh) | 2015-11-24 | 2015-11-24 | 一种用于产后自汗治疗与护理的中药丸剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510821834.3A CN105267757A (zh) | 2015-11-24 | 2015-11-24 | 一种用于产后自汗治疗与护理的中药丸剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105267757A true CN105267757A (zh) | 2016-01-27 |
Family
ID=55138147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510821834.3A Withdrawn CN105267757A (zh) | 2015-11-24 | 2015-11-24 | 一种用于产后自汗治疗与护理的中药丸剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105267757A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105687824A (zh) * | 2016-01-28 | 2016-06-22 | 张妮 | 一种用于治疗产后盗汗的中药冲剂及制备方法 |
CN108355061A (zh) * | 2018-04-28 | 2018-08-03 | 冷立娟 | 一种用于缓解和治疗产后自汗征的中药冲剂及制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101112547A (zh) * | 2007-08-29 | 2008-01-30 | 北京艺信堂医药研究所 | 一种治疗产后自汗的中药制剂 |
CN103006999A (zh) * | 2013-01-03 | 2013-04-03 | 王玉莲 | 一种用于肾结石预防、治疗与护理的丸剂 |
-
2015
- 2015-11-24 CN CN201510821834.3A patent/CN105267757A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101112547A (zh) * | 2007-08-29 | 2008-01-30 | 北京艺信堂医药研究所 | 一种治疗产后自汗的中药制剂 |
CN103006999A (zh) * | 2013-01-03 | 2013-04-03 | 王玉莲 | 一种用于肾结石预防、治疗与护理的丸剂 |
Non-Patent Citations (3)
Title |
---|
吴品琮等: "《吴氏妇科精粹》", 30 June 2008, 宁波出版社 * |
时纪田等: "《家庭实用中草药典》", 30 June 2009, 天津古籍出版社 * |
赵玉林: "王应萱老中医治产后汗证验案三则", 《河南中医》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105687824A (zh) * | 2016-01-28 | 2016-06-22 | 张妮 | 一种用于治疗产后盗汗的中药冲剂及制备方法 |
CN108355061A (zh) * | 2018-04-28 | 2018-08-03 | 冷立娟 | 一种用于缓解和治疗产后自汗征的中药冲剂及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103860969A (zh) | 一种增肥的中药 | |
CN104083740A (zh) | 一种用于增肥的内服中药 | |
CN105687824A (zh) | 一种用于治疗产后盗汗的中药冲剂及制备方法 | |
CN105148039A (zh) | 一种用于缓解肿瘤放疗后反应的中药药丸及制备方法 | |
CN105148249A (zh) | 一种用于治疗经行浮肿的中药丸剂及制备方法 | |
CN103432412A (zh) | 一种治疗乳腺增生的药物及其制备方法 | |
CN104225532B (zh) | 治疗强直性脊柱炎的健脾温肾丸 | |
CN105267757A (zh) | 一种用于产后自汗治疗与护理的中药丸剂及制备方法 | |
CN103054073B (zh) | 一种养颜鱼鳞冻及其制备方法 | |
CN105497784A (zh) | 一种用于治疗血栓性浅静脉炎的中药丸剂及制备方法 | |
CN105394282A (zh) | 一种可降压降糖降脂的葛根保健茶 | |
CN104524422B (zh) | 一种治疗男性乳房发育症的药丸及制备方法 | |
CN105343866A (zh) | 一种用于治疗寒饮咳嗽的中药片剂及制备方法 | |
CN105250569A (zh) | 一种用于治疗末梢神经炎的中药丸剂及制备方法 | |
CN105288427A (zh) | 一种用于治疗肝郁气滞型胃潴留的中药丸剂及制备方法 | |
CN105381128A (zh) | 一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法 | |
CN104800780A (zh) | 一种治疗多囊卵巢综合征的中药制剂及其制备方法 | |
CN108853340A (zh) | 一种滋养肝肾的中药及其制备方法 | |
CN105434934A (zh) | 一种用于治疗妇科更年期综合症的中药丸剂及制备方法 | |
CN105434933A (zh) | 一种用于治疗热汗症的中药丸剂及制备方法 | |
CN105148038A (zh) | 一种用于治疗ct检查后不良反应的中药丸剂及制备方法 | |
CN105434932A (zh) | 一种用于治疗女性性早熟综合征的中药丸剂及制备方法 | |
CN105477462A (zh) | 一种用于治疗肥胖症的中药丸剂及制备方法 | |
CN105833091A (zh) | 一种治疗糖尿病的中药组合物 | |
CN105748968A (zh) | 一种用于巨幼细胞性贫血辅助治疗的药丸及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160127 |
|
WW01 | Invention patent application withdrawn after publication |